Cubist Systematic Strategies’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-20,329
Closed -$237K 2889
2024
Q1
$252K Buy
20,329
+5,166
+34% +$86.1K ﹤0.01% 2970
2023
Q4
$402K Buy
+15,163
New +$442K ﹤0.01% 2639
2023
Q2
Sell
-1,536
Closed -$50.4K 3422
2023
Q1
$47.6K Sell
1,536
-114,745
-99% -$3.7M ﹤0.01% 3571
2022
Q4
$2.34M Buy
116,281
+102,363
+735% +$2.19M 0.01% 1714
2022
Q3
$196K Sell
13,918
-189,814
-93% -$2.55M ﹤0.01% 3777
2022
Q2
$1.53M Buy
203,732
+16,754
+9% +$139K 0.01% 2102
2022
Q1
$1.9M Buy
186,978
+110,152
+143% +$1.41M 0.02% 1523
2021
Q4
$1.86M Buy
76,826
+33,730
+78% +$659K 0.02% 1432
2021
Q3
$588K Buy
+43,096
New +$310K 0.01% 1918

Other funds holding AEHR

Cubist Systematic Strategies's AEHR Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Aehr Test Systems (AEHR) in Q2 2024, closing a stake of 20,329 shares — an estimated $237K sold.

Cubist Systematic Strategies first reported a position in AEHR in Q3 2021 and held it in 9 quarters. The position peaked at $2.34M in Q4 2022. 119 funds tracked by Wall St. Rank hold AEHR as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Aehr Test Systems position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 20,329 Aehr Test Systems shares in Q2 2024, an estimated $237K.
  • Cubist Systematic Strategies first reported a position in Aehr Test Systems in Q3 2021 and held it in 9 quarters.
  • Cubist Systematic Strategies's Aehr Test Systems position peaked at $2.34M in Q4 2022.
  • 119 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.